BofA analyst Eli Abboud raised the firm's price target on Nasdaq to $113 from $109 and keeps a Buy rating on the shares. Following a Q1 EPS beat, the firm is raising its 2026, 2027 and 2028 EPS estimates to embed higher Capital Markets Technology and Index revenue, notes the analyst, who thinks AI concerns about Nasdaq are "unjustified" and argues that the company is "a clear beneficiary of the technology."
